Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
about
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancerThe Effects of Sequence Variation on Genome-wide NRF2 Binding--New Target Genes and Regulatory SNPsThe engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancerThe Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumorsThe involvement of NRF2 in lung cancerRadiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of esophageal squamous cancers.STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.The Nrf2-ARE pathway is associated with Schisandrin b attenuating benzo(a)pyrene-Induced HTR cells damages in vitro.Controversy about pharmacological modulation of Nrf2 for cancer therapyEmerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Antiapoptotic gene BAG-1 vector structure of RNA interference and endogenous targeted screening in colon cancer cell lines.Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy.Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy.Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy.HSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK.Combined treatment of cholangiocarcinoma with interventional radiofrequency hyperthermia and heat shock protein promoter-mediated HSV-TK gene therapy
P2860
Q28387975-DB7BA355-A5A4-4FB2-B249-C60781579F21Q28388133-BC775D5D-6A0C-4A07-BD89-C078E53246DFQ30689378-F22A4E3E-E95E-427B-979F-E699CABD5DC6Q33659621-C0F542BD-B5A7-45F8-87AB-F040FB429457Q36087611-CB98D456-4E62-44F6-A870-9C9CC22E9DCCQ36734146-D8E76F35-8EF9-4CA9-8060-A7DEBB257C0EQ37298320-5AE53683-9442-4A73-BD55-35844BC68F3CQ37668555-45F43872-558F-4453-BCCF-2623AB13D399Q38740553-8837A7A2-FD2C-4885-98D8-FE27D07AED43Q38835943-566932DB-B284-4674-8C66-28E8552964BBQ38869922-76C37D7E-525A-4FC9-A4C0-C6D02EBA3974Q39092635-BB99D06A-E665-44D1-9B01-391BE70BA4EAQ47227033-7B8B0BC1-0471-40E6-8E8D-2517D7436183Q49301847-7C15B4C4-A60A-4340-A9D5-1491FF646876Q53831194-69175CE3-94EB-4187-B0EC-A72EE559EF62Q54976438-F0E56632-E462-4213-867A-851F1B7CBB2CQ54977772-8F688614-8FB8-4E1F-9059-1C5F8C226D74Q58804572-4F11C24E-9C5D-4A6E-A38E-5ED7F15F4B09
P2860
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
@en
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
@nl
type
label
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
@en
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
@nl
prefLabel
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
@en
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
@nl
P2093
P50
P1433
P1476
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
@en
P2093
Ann-Marie Määttä
Anna-Kaisa Ruotsalainen
Hanna M Leinonen
Hanna P Lesch
Haritha Samaranayake
Heidi M Laitinen
Jari P Lappalainen
Jere T Pikkarainen
P304
P356
10.1158/0008-5472.CAN-12-1166
P407
P50
P577
2012-10-04T00:00:00Z